| Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis (NCT03691818) | Tianjin XinChen-Techfields Pharma Co., LTD. | 2018-07-16 |
| Fertility-sparing Management Using High-dose Oral Progestin in Young Women With Endometrial Cancer (NCT03567655) | Asan Medical Center | 2018-07-15 |
| Platelet Function With Various Storage Techniques (NCT03338660) | Northwell Health | 2018-07-15 |
| Re-challenge Pembrolizumab Study as a Second or Further Line in Patients With Advanced NSCLC (NCT03526887) | Spanish Lung Cancer Group | 2018-07-15 |
| SELIBORDARA: Selinexor, Bortezomib and Daratumumab in Multiple Myeloma (NCT03589222) | PETHEMA Foundation | 2018-07-15 |
| Green Tea Extract on Soluble RAGE in Patients With Diabetic Nephropathy (NCT03622762) | Centro Universitario de Ciencias de la Salud, Mexico | 2018-07-15 |
| Long Term Extension Trial of Setmelanotide (NCT03651765) | Rhythm Pharmaceuticals, Inc. | 2018-07-15 |
| Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH (NCT03556020) | PhaseBio Pharmaceuticals Inc. | 2018-07-15 |
| Neoadjuvant Immunotherapy With Durvalumab and Tremelimumab for Bladder Cancer Patients Ineligible for Cisplatin (NCT03234153) | Insel Gruppe AG, University Hospital Bern | 2018-07-15 |
| Modulating ApoE Signalling to Reduce Brain Inflammation, deLirium and postopErative Cognitive Dysfunction (NCT03802396) | Miles Berger, MD PhD | 2018-07-15 |
| A Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas (NCT03591666) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2018-07-15 |
| Sedation During Spinal Anesthesia (NCT03133780) | Assiut University | 2018-07-14 |
| Does Antibiotic Prophylaxis Reduce Wound Complications After Vulvar Excision of Premalignant Lesions (NCT03578965) | Washington University School of Medicine | 2018-07-13 |
| A Study to Evaluate the Effect of GFA-918 on Serum Triglyceride Levels in Individuals With Elevated Serum Triglyceride (NCT04754373) | BIO-CAT Microbials, LLC | 2018-07-13 |
| A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication (NCT03557931) | Astellas Pharma Global Development, Inc. | 2018-07-13 |
| Gemcitabine, Cisplatin, Plus Nivolumab in Patients With Muscle-invasive Bladder Cancer With Selective Bladder Sparing (NCT03558087) | Matthew Galsky | 2018-07-13 |
| A Research Study to Characterize the Pharmacodynamics and Safety of Repeat Dose SP-102 (NCT03613662) | Semnur Pharmaceuticals, Inc. | 2018-07-13 |
| Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5) (NCT03562377) | LEO Pharma | 2018-07-13 |
| Meru Health Ascend Mobile Intervention for Depression in Middle Aged and Older Adults (NCT03652948) | Palo Alto Veterans Institute for Research | 2018-07-12 |
| CVM-1118 and Sorafenib Combination in Subjects With Advanced Hepatocellular Carcinoma (NCT03582618) | TaiRx, Inc. | 2018-07-12 |
| Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS (NCT03534323) | Dana-Farber Cancer Institute | 2018-07-12 |
| 5-ALA Patch-PDT of Actinic Keratosis on the Upper Extremities (NCT03606122) | photonamic GmbH & Co. KG | 2018-07-12 |
| Anlotinib in Metastatic HER2 Negative Breast Cancer (NCT04002284) | Peng Yuan | 2018-07-12 |
| A Novel TBI Free Conditioning Protocol for Haploidentical Transplant in Acquired Aplastic Anemia: (NCT03955601) | National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | 2018-07-12 |
| Safety and Efficacy of THN102 in Patients With Parkinson's Disease and Excessive Daytime Sleepiness (NCT03624920) | Theranexus | 2018-07-12 |
| Pilot Study of Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's Disease (NCT03476317) | Children's Hospital of Philadelphia | 2018-07-12 |
| A Safety and Efficacy Study of Infusions of HepaStem in Urea Cycle Disorders Pediatric Patients (NCT03884959) | HLB Cell Co., Ltd. | 2018-07-12 |
| Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma (NCT03526679) | National Taiwan University Hospital | 2018-07-12 |
| Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers (NCT03515538) | EpicentRx, Inc. | 2018-07-12 |
| Study for Evaluation of Murlentamab (GM102) Anti-tumoral Activity in Colorectal Cancers (NCT03799731) | GamaMabs Pharma | 2018-07-11 |
| Gemcitabine Plus Ascorbate for Sarcoma in Adults (NCT03468075) | Mohammed Milhem, MBBS | 2018-07-11 |
| Safety and Efficacy of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis (NCT03618784) | Kang Stem Biotech Co., Ltd. | 2018-07-11 |
| Olaparib in People With Malignant Mesothelioma (NCT03531840) | National Cancer Institute (NCI) | 2018-07-11 |
| Nevanimibe HCl for the Treatment of Classic CAH (NCT03669549) | Millendo Therapeutics US, Inc. | 2018-07-11 |
| Adalimumab Microneedles in Healthy Volunteers (NCT03607903) | Centre for Human Drug Research, Netherlands | 2018-07-11 |
| Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab. (NCT03552276) | Sun Pharmaceutical Industries Limited | 2018-07-11 |
| A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer Subjects With the Overexpression of HER2 (NCT03556345) | RemeGen Co., Ltd. | 2018-07-10 |
| Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors (NCT03583086) | Vanderbilt-Ingram Cancer Center | 2018-07-10 |
| IA Carboplatin + Radiotherapy in Relapsing GBM (NCT03672721) | Université de Sherbrooke | 2018-07-10 |
| Rivaroxaban vs Warfarin in Patients With Metallic Prosthesis (NCT03566303) | Hospital Geral Roberto Santos | 2018-07-10 |
| Stellate Ganglion Blockade in Post-Menopausal Women (NCT02907983) | Northwestern University | 2018-07-10 |
| Metformin Treatment for Colon Cancer (NCT03359681) | Zealand University Hospital | 2018-07-10 |
| A Long-Term Follow-Up Study of Haemophilia B Patients Who Have Undergone Gene Therapy (NCT03641703) | Spur Therapeutics | 2018-07-10 |
| Randomized, Double-Blind, Placebo-Controlled, Safety and Tolerability Study of ITI-214 in Patients With Heart Failure (NCT03387215) | Intra-Cellular Therapies, Inc. | 2018-07-10 |
| Clinical Study of Apatinib in the Treatment of Platinum Resistant Recurrent Ovarian Cancer (NCT03587129) | First Affiliated Hospital of Harbin Medical University | 2018-07-10 |
| Efficacy & Safety of RPh201 Treatment in Patients With Previous Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) (NCT03547206) | Regenera Pharma Ltd | 2018-07-10 |
| Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancer (NCT03566485) | Vanderbilt-Ingram Cancer Center | 2018-07-10 |
| A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis (NCT03585296) | Aclaris Therapeutics, Inc. | 2018-07-10 |
| A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder (NCT03566134) | Dong-A ST Co., Ltd. | 2018-07-10 |
| BEACON - ABC in Recurrent Platinum Resistant HGSOC (NCT03363867) | Peter MacCallum Cancer Centre, Australia | 2018-07-10 |
| Stem Cell Transplant to Treat Patients With Favorable or Intermediate Risk Minimal Residual Disease Negative Acute Myeloid Leukemia (NCT03515707) | Fred Hutchinson Cancer Center | 2018-07-10 |
| A Trial Evaluating Surufatinib Efficacy and Safety in Biliary Tract Carcinoma Patients (NCT03873532) | Hutchison Medipharma Limited | 2018-07-10 |
| A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Heart Attack (NCT03487445) | Viatris Innovation GmbH | 2018-07-10 |
| A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site (NCT03498521) | Hoffmann-La Roche | 2018-07-10 |
| Clinical Application of Mg Based Biodegradable Material for Fracture Fixation in the Adult Skeleton (NCT05245981) | Medical University of Graz | 2018-07-09 |
| Peptide Receptor Radionuclide Therapy Administered to Participants With Meningioma With 67Cu-SARTATE™ (NCT03936426) | Clarity Pharmaceuticals Ltd | 2018-07-09 |
| Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI (NCT03602261) | OPKO Health, Inc. | 2018-07-09 |
| A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X Syndrome (NCT03569631) | Tetra Discovery Partners | 2018-07-09 |
| ANAVEX2-73 Study in Parkinson's Disease Dementia (NCT03774459) | Anavex Life Sciences Corp. | 2018-07-09 |
| Pembrolizumab in Untreated B-Cell Non-Hodgkin Lymphoproliferative Diseases (NCT03498612) | University of Washington | 2018-07-09 |
| Study to Assess Potential Immune Interference When GlaxoSmithKline (GSK) Biologicals' MenABCWY Vaccine is Administered to Healthy Subjects Aged 10-25 Years (NCT03587207) | GlaxoSmithKline | 2018-07-09 |
| A Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001) (NCT03594058) | Velicept Therapeutics, Inc. | 2018-07-09 |
| Study of CA-008 (Vocacapsaicin) in Bunionectomy Patients (NCT03599089) | Concentric Analgesics | 2018-07-09 |
| The Insulin-Only Bionic Pancreas Bridging Study (NCT03565666) | Massachusetts General Hospital | 2018-07-09 |
| Phase II Umbrella Study Directed by Next Generation Sequencing (NCT03574402) | Guangdong Association of Clinical Trials | 2018-07-09 |
| A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Hypofraction Radiotherapy in Patients With NSCLC (NCT03557411) | Shandong Cancer Hospital and Institute | 2018-07-09 |
| Topical Remetinostat in Treating Patient With Cutaneous Basal Cell Cancer (NCT03180528) | Kavita Sarin | 2018-07-07 |
| Atezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain Metastasis (NCT03526900) | Spanish Lung Cancer Group | 2018-07-07 |
| A Study to Evaluate the Safety and Immunogenicity for Regimen Selection of Ad26.RSV.preF and/or RSV preF Protein Combinations Followed by Expanded Safety Evaluation in Adults Aged 60 Years and Older (NCT03502707) | Janssen Vaccines & Prevention B.V. | 2018-07-06 |
| Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast Cancer (NCT03326102) | Daehwa Pharmaceutical Co., Ltd. | 2018-07-06 |
| Study of CDX-3379, a Human Monoclonal Antibody Targeting ERBB3, in Combination With the MEK Inhibitor, Trametinib, in Patients With Advanced Stage NRAS Mutant and BRAF/NRAS Wildtype (WT) Melanoma (NCT03580382) | NYU Langone Health | 2018-07-06 |
| Efficacy of Combined Blood Clot and Platelet Rich Fibrin Scaffolds in Regeneration of Necrotic Immature Permanent Teeth (NCT04390854) | Nourhan M.Aly | 2018-07-06 |
| E GFR TKI and EGF-P TI C Ombination in EGFR mutA nt NSCL C (NCT03623750) | Instituto Oncológico Dr Rosell | 2018-07-06 |
| A Feasibility Study of N-acetylcysteine for Self-injurious Behavior in Children With Autism Spectrum Disorder (NCT03008889) | Emory University | 2018-07-05 |
| Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease. Extension to HP-CD-CL-2002 Clinical Study (NCT03775538) | Herantis Pharma Plc. | 2018-07-05 |
| Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) (NCT03392909) | University of Southern California | 2018-07-05 |
| Progesterone in Patients With Placenta Previa (NCT03633175) | Ain Shams University | 2018-07-05 |
| A Study of Carfilzomib Plus Dexamethasone in Adults With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers (NCT03512353) | Amgen | 2018-07-05 |
| A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus (NCT03617536) | Cara Therapeutics, Inc. | 2018-07-05 |
| Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT) (NCT03531957) | Asana BioSciences | 2018-07-05 |
| Fecal Microbial Transplantation for Ileal Pouch Anal Anastomosis Patients (NCT04336319) | Tel-Aviv Sourasky Medical Center | 2018-07-05 |
| Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria (NCT03520036) | Tanabe Pharma America, Inc. | 2018-07-05 |
| Obstructive Sleep Apnea and Telomere Length (NCT04872816) | Associação Fundo de Incentivo à Pesquisa | 2018-07-05 |
| Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis (NCT03573336) | Bayer | 2018-07-04 |
| Study of Gefapixant (MK-7264) in Acute Cough for Participants With Induced Viral Upper Respiratory Tract Infection (URTI) (MK-7264-013) (NCT03569033) | Merck Sharp & Dohme LLC | 2018-07-04 |
| A Study of mDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal Carcinoma (NCT03519295) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2018-07-03 |
| Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer (NCT03427814) | BeiGene | 2018-07-03 |
| Evaluating the Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for HIV Prevention During Pregnancy and Postpartum (NCT03386578) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-07-03 |
| EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation (NCT03200340) | Enzychem Lifesciences Corporation | 2018-07-03 |
| Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cell Cancer Before Surgery (NCT03565783) | M.D. Anderson Cancer Center | 2018-07-03 |
| FX-322 in Sensorineural Hearing Loss (NCT03616223) | Frequency Therapeutics | 2018-07-03 |
| St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Nalmefene (NCT03278886) | Boston Medical Center | 2018-07-03 |
| ANAVEX2-73 for Treatment of Early Alzheimer's Disease (NCT03790709) | Anavex Life Sciences Corp. | 2018-07-03 |
| Phase 2 Study to Examine Grape Seed Extract as an Anti-Oligomerization Agent in Alzheimer's Disease (AD) (NCT02033941) | Hillel Grossman | 2018-07-03 |
| Testing JNJ-42756493 (Erdafitinib) as Potentially Targeting Treatment in Cancers With FGFR Mutations or Fusions (MATCH - Subprotocol K2) (NCT06351371) | National Cancer Institute (NCI) | 2018-07-03 |
| [68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR) (NCT03724253) | Advanced Accelerator Applications | 2018-07-03 |
| Efficacy and Safety of Ascending Dosages of Moxidectin and Moxidectin-albendazole Against Trichuris Trichiura (NCT03501251) | Swiss Tropical & Public Health Institute | 2018-07-03 |
| Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients (NCT03587844) | Memorial Sloan Kettering Cancer Center | 2018-07-03 |
| A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation (NCT03556332) | Memorial Sloan Kettering Cancer Center | 2018-07-02 |
| Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases (NCT03367546) | Masonic Cancer Center, University of Minnesota | 2018-07-02 |